Nitroglycerin 0.1mg/hr, 0.2mg/hr, 0.3mg/hr, 0.4mg/hr, 0.6mg/hr, 0.8mg/hr; transdermal patches. The principal pharmacological action is relaxation of vascular smooth muscle and consequent ...

Transdermal contraceptive patches provide a more convenient delivery system for combined hormonal birth control than daily oral contraceptives. Clinical trials demonstrate that greater numbers of ...

The first ondansetron orally dissolving film (ODF) has been approved in Japan, validating TAHO’s platform technology from prototype to commercial product. Transdermal patches and ODFs can ...

They were patch-tested with lanolin, lactose, nitroglycerin 0.2mg/mL in water ... is associated not only with the active ingredients of transdermal systems but also with other components.